<DOC>
	<DOCNO>NCT02241993</DOCNO>
	<brief_summary>The purpose study test accuracy benefit two glucose sensor ( one sensor alone ) position : 2mm , 10mm , 20mm , 30mm apart . It yet know close two sensor still work correctly .</brief_summary>
	<brief_title>The Multi-Sensor Distance Accuracy Study</brief_title>
	<detailed_description>An artificial pancreas system likely require multiple glucose sense element function safely . It yet know close two glucose sensor place still work properly . Meaning , one reading inaccurately , position adjacent , read inaccurately also , defeat purpose two sensor . Twenty adult subject Type 1 diabetes wear four Medtronic REAL-Time glucose sensor two separate 10-hour study . The inter-sensor distance pair test : 2 , 10 , 20 , 30mm apart . The sensor insert day prior study day allow signal stabilization calibration . During study day , arterialize venous blood drawn every 15 minute measure blood glucose . The sensor value interstitial value record sensor receiver time point . Subjects feed two standardized meal give pre-meal insulin base typical insulin carbohydrate ratio .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . Type 1 diabetes mellitus diagnose least 6 month 2 . Current usage multiple daily injection subcutaneous insulin pump treatment 3 . Age 1865 year 4 . HbA1c 6.0 9.5 % screen visit 5 . BMI 2135 6 . Willingness follow study procedure , include attend clinic visit 7 . Willingness sign inform consent HIPAA document Subjects present follow include study . 1 . Pregnancy Lactation : woman childbearing potential requirement negative urine pregnancy test . 2 . Renal insufficiency ( serum creatinine 2.0 mg/dL great ) . Serum ALT AST equal great 3 time upper limit normal ; hepatic synthetic insufficiency define serum albumin le 3.3 g/dL ; serum bilirubin 2 . 3 . Hematocrit le equal 34 % . 4 . Congestive heart failure , NYHA class III IV . 5 . Visual impairment prevent read glucose meter value . 6 . Active coronary artery disease manifest unstable angina , myocardial infarction therapeutic coronary percutaneous procedure ( e.g. , PTCA , stent placement ) CABG within past 4 month . 7 . Active foot ulceration . 8 . Severe peripheral arterial disease characterize ischemic rest pain severe claudication . 9 . Cerebrovascular accident within past 6 month . 10 . Active alcohol abuse , substance abuse , severe mental illness ( judge principal investigator ) . 11 . Active malignancy , except basal cell squamous cell skin cancer . 12 . Major surgical operation within 30 day prior screen . 13 . Seizure disorder ( epilepsy ) . 14 . Any concurrent illness , diabetes , control stable therapeutic regimen . 15 . Currently administration oral parenteral corticosteroid . 16 . Use investigational drug within 30 day prior screen . 17 . Bleeding disorder , treatment warfarin , platelet count 50,000 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>glucose sensor</keyword>
	<keyword>Inter-sensor distance</keyword>
</DOC>